Publication | Closed Access

The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: A placebo-controlled randomized clinical trial

Metabolic SyndromeDiabetes ManagementInsulin ManagementDiabetesPharmacologyLate Type 2Vascular BiologyEndothelial FunctionDiabetes MellitusInsulin-sensitizing AgentMedicine